2022
DOI: 10.1002/jhbp.1296
|View full text |Cite
|
Sign up to set email alerts
|

Central pancreatectomy prevents postoperative diabetes

Abstract: Background: Central pancreatectomy (CP) can be performed as an alternative surgical approach to distal pancreatectomy (DP) in the treatment of benign or low-grade malignant lesions located in the neck and body of the pancreas, aiming to reduce loss of parenchyma and therefore organ failure. The objective of this study was to evaluate the short-and long-term outcome of CP in comparison to DP. Methods: Patients who received CP in a large tertiary care pancreatic surgery center between 2001 and 2020 were identifi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 31 publications
0
6
0
Order By: Relevance
“…The main purpose of CP is to preserve pancreatic endocrine function by preserving the pancreatic tail and to maintain patient quality of life. Our literature search for articles on the comparison between CP and DP identified several studies published since 2010 [14][15][16][17][18][19][20][21][22][23][24][25][26][27] that had compared postoperative endocrine function between CP and DP cases (Table 1). As shown in Table 1, most of the studies presented the results of single-center retrospective studies or meta-analyses aggregating those retrospective studies.…”
Section: Clinical Significance Of Pancreatic Tail Preservation In Cpmentioning
confidence: 99%
“…The main purpose of CP is to preserve pancreatic endocrine function by preserving the pancreatic tail and to maintain patient quality of life. Our literature search for articles on the comparison between CP and DP identified several studies published since 2010 [14][15][16][17][18][19][20][21][22][23][24][25][26][27] that had compared postoperative endocrine function between CP and DP cases (Table 1). As shown in Table 1, most of the studies presented the results of single-center retrospective studies or meta-analyses aggregating those retrospective studies.…”
Section: Clinical Significance Of Pancreatic Tail Preservation In Cpmentioning
confidence: 99%
“…Central pancreatectomy (CP) is a rarely performed [ 1 , 2 ] and controversial type of pancreatic resection [ 3 ] that is sometimes used as an alternative to distal pancreatectomy mainly for certain benign and low-grade malignant tumors of the pancreatic body and isthmus [ 4 ]. The principal advantage of a CP over a distal pancreatectomy is a better preservation of postoperative pancreatic functions, particularly the endocrine one [ 5 , 6 , 7 , 8 ]. However, a CP is associated with high morbidity rates (higher than distal pancreatectomies) [ 5 , 6 , 7 , 9 ] and exceptionally high rates of postoperative pancreatic fistulae (POPF) [ 2 , 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…The jejunum is primarily used for distal pancreatic stump anastomoses after CP [ 1 , 4 , 8 , 11 , 12 , 16 ]. However, in a few centers, an anastomosis with the stomach is preferred for the distal pancreatic stump after CP [ 10 , 17 , 18 ], especially in a minimally invasive approach [ 19 , 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…CP generally can be performed as an alternative surgical approach to DP in the treatment of benign or low-grade malignant lesions located in the pancreatic neck and body in order to reduce the loss of parenchyma and therefore postoperative endocrine and exocrine pancreatic failure [9,10]. Thus, CP offers improved endocrine and exocrine longterm results at the expense of a higher risk of postpancreatectomy hemorrhage (PPH) and POPF without increased perioperative mortality [10].…”
mentioning
confidence: 99%
“…CP generally can be performed as an alternative surgical approach to DP in the treatment of benign or low-grade malignant lesions located in the pancreatic neck and body in order to reduce the loss of parenchyma and therefore postoperative endocrine and exocrine pancreatic failure [9,10]. Thus, CP offers improved endocrine and exocrine longterm results at the expense of a higher risk of postpancreatectomy hemorrhage (PPH) and POPF without increased perioperative mortality [10]. Indications for CP are the following: benign or borderline lesions located in the pancreatic neck or proximal body, inability of enucleation of the lesion located within the pancreatic isthmus/proximal body, and trauma-related injury to the isthmus/proximal body [1,11,12].…”
mentioning
confidence: 99%